Cheers for your feedback! You have all been consistent in reporting your perception that the company is being well lead and seemingly in charge of its destiny.
In my view, tis is the best sort of company to be in, particularly in the current climate - no debt, fully-owned IP with obvious potential, growing (testing) markets, competitive products, on-going diversification, a near-monopoly start-up in the world's largest testing market (China) and - based on your feedback - a non-hype, no-nonsense board that is focussed and excited about several projects (SiYi, Bioscreens and Oraline8 - at the very least).
Thanks again guys.
SBN Price at posting:
0.7¢ Sentiment: LT Buy Disclosure: Held
